Advertisement

Topics

EMA Grants Alnylam Accelerated Assessment Of Patisiran

08:05 EST 13 Nov 2017 | FinanzNachrichten

WASHINGTON (dpa-AFX) - Alnylam Pharmaceuticals Inc. (ALNY) said that the Committee for Medicinal Products for Human Use or CHMP of the European Medicines Agency or EMA has granted an accelerated a...

Original Article: EMA Grants Alnylam Accelerated Assessment Of Patisiran

NEXT ARTICLE

More From BioPortfolio on "EMA Grants Alnylam Accelerated Assessment Of Patisiran"

Advertisement
Quick Search
Advertisement
Advertisement